Compile Data Set for Download or QSAR
Report error Found 197 Enz. Inhib. hit(s) with all data for entry = 6511
TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135525(US8853258, 176)
Affinity DataIC50: 0.0303nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135565(US8853258, 218)
Affinity DataIC50: 0.0340nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135527(US8853258, 178)
Affinity DataIC50: 0.0592nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135477(US8853258, 44)
Affinity DataIC50: 0.0669nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135531(US8853258, 182)
Affinity DataIC50: 0.0674nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135562(US8853258, 215)
Affinity DataIC50: 0.0842nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135460(US8853258, 5)
Affinity DataIC50: 0.120nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135494(US8853258, 104)
Affinity DataIC50: 0.127nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135478(US8853258, 47)
Affinity DataIC50: 0.132nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135495(US8853258, 107)
Affinity DataIC50: 0.134nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135530(US8853258, 181)
Affinity DataIC50: 0.138nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135497(US8853258, 109)
Affinity DataIC50: 0.144nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135498(US8853258, 113)
Affinity DataIC50: 0.148nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135502(US8853258, 127)
Affinity DataIC50: 0.150nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135533(US8853258, 184)
Affinity DataIC50: 0.155nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135528(US8853258, 179)
Affinity DataIC50: 0.172nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135496(US8853258, 108)
Affinity DataIC50: 0.176nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135472(US8853258, 23)
Affinity DataIC50: 0.180nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135484(US8853258, 62)
Affinity DataIC50: 0.185nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM30550(US8853258, 194)
Affinity DataIC50: 0.195nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135518(US8853258, 169)
Affinity DataIC50: 0.200nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135506(US8853258, 136)
Affinity DataIC50: 0.205nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135483(US8853258, 59)
Affinity DataIC50: 0.213nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135503(US8853258, 128)
Affinity DataIC50: 0.232nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135516(US8853258, 167)
Affinity DataIC50: 0.235nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135560(US8853258, 212)
Affinity DataIC50: 0.237nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135535(US8853258, 186)
Affinity DataIC50: 0.238nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135549(US8853258, 201)
Affinity DataIC50: 0.240nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135513(US8853258, 162)
Affinity DataIC50: 0.241nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135490(US8853258, 83)
Affinity DataIC50: 0.242nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135539(US8853258, 190)
Affinity DataIC50: 0.246nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135459(US8853258, 2)
Affinity DataIC50: 0.260nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135492(US8853258, 91)
Affinity DataIC50: 0.266nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135547(US8853258, 199)
Affinity DataIC50: 0.266nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135564(US8853258, 217)
Affinity DataIC50: 0.278nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135465(US8853258, 13)
Affinity DataIC50: 0.290nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135482(US8853258, 57)
Affinity DataIC50: 0.295nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135514(US8853258, 165)
Affinity DataIC50: 0.295nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135526(US8853258, 177)
Affinity DataIC50: 0.306nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135462(US8853258, 7)
Affinity DataIC50: 0.310nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135463(US8853258, 9)
Affinity DataIC50: 0.320nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135573(US8853258, 226)
Affinity DataIC50: 0.320nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM30560(US8853258, 247)
Affinity DataIC50: 0.325nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135501(US8853258, 126)
Affinity DataIC50: 0.329nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135474(US8853258, 34)
Affinity DataIC50: 0.331nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135476(US8853258, 42)
Affinity DataIC50: 0.335nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135507(US8853258, 138)
Affinity DataIC50: 0.335nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135508(US8853258, 157)
Affinity DataIC50: 0.337nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135537(US8853258, 188)
Affinity DataIC50: 0.348nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetUDP-3-O-acyl-N-acetylglucosamine deacetylase(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

US Patent
LigandPNGBDBM135485(US8853258, 63)
Affinity DataIC50: 0.356nMpH: 8.0Assay Description:IC50 determination in the LpxC enzyme assay was carried out in a similar manner to that described by Malikzay et al in the 2006 Poster, Screening Lpx...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 197 total ) | Next | Last >>
Jump to: